Lilly Sees Payoff In China By Boning Up On Tax And Patent Law
This article was originally published in PharmAsia News
SAN FRANCISCO - Adept management of tax, patent and government relations issues particular to China can help Western pharmaceutical companies reap the benefits of working in the vast, developing market while avoiding pitfalls
You may also be interested in...
BEIJING - China's ongoing battle to curtail corruption was the topic of PharmAsia News' Aug. 27 audioconference, "Anti-Bribery Compliance in China - Avoiding the Pitfalls."
Accelovance’s Stephen Trevisan And Robert deGroof On China’s Clinical Research Landscape: An Interview With PharmAsia News (Part 2 of 2)
[Editor's Note: This is part two of a two-part interview. Part one appeared in PharmAsia News, May 15, 2008.]